Stock listing

NASDAQ:PCSC Perceptive Capital Solutions Corp Stock

Home listing (NASDAQ) of Perceptive Capital Solutions Corp

Follow Perceptive Capital Solutions Corp into a list and get an email when it puts out news.

Perceptive Capital Solutions Corp logo
Ticker
NASDAQ:PCSC
Asset type
Stock
Sector
Financials
Industry
Shell companies & SPACs
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Perceptive Capital Solutions Corp news

Perceptive Capital Solutions Corp on 6ix

Sector
Financials
Industry
Shell companies & SPACs
News releases
3 in the last 12 months · 4 in all · newest Jul 9, 2026 · oldest 2024
Decks
3 decks · latest Jul 9, 2026

Where Perceptive Capital Solutions Corp is listed

ListingExchangeCountryCurrency
NASDAQ:PCSC · Home listing · This pageNASDAQUnited StatesUSD
BOATS:PCSCBOATSUnited StatesUSD

Valuation

Statements: 4 quarters to Jun 30, 2026

Enterprise value
No market cap
P/E
No market cap
EV/sales
No market cap
EV/EBITDA
No market cap
Price/book
No market cap
Gross margin
Not reported
Operating margin
−424.2%
Net margin
−92.3%
Debt to equity
Negative equity
Beta vs S&P 500
Under 6 months of closes

Team and board

Officers

OfficerRole
Aaron ElliottChief Executive Officer
Deepa PakianathanChief Executive Officer
Linh H. LeChief Financial Officer
Thomas FitzpatrickChief Legal Officer
Sally HowardSenior Vice President, Regulatory and Quality
Jimmy LinChief Scientific Officer
Julie TranChief People Officer
Riley EnnisCo-Founder and Chief Product Officer
Robert GuigleyChief Commercial Officer

Board

DirectorRole
Douglas VanOortDirector

Events

QuarterResultsShare move
Q2 2026Jul 15, 2026+1.3%
Q3 2025Nov 13, 2025
Q2 2025Aug 13, 2025
Q1 2025May 12, 2025 · After close
Q4 2024Mar 19, 2025

Open Events

Decks

DeckKindSlidesDate
SPAC Merger (July 2026)SPAC merger17 slidesJul 9, 2026
SPAC Merger (May 2026)SPAC merger87 slidesMay 19, 2026
SPAC Merger (December 2025)SPAC merger52 slidesDec 5, 2025

Open Decks

Financings

RaiseDate
Private placement of common stock (PIPE)
Announced: about US$240M · US$10 a share · Jefferies +1
Dealers: Jefferies (co-lead), Leerink Partners (co-lead)
Buyers: Perceptive Advisors; RA Capital; ADAR1 Capital; Bain Capital Life Sciences; Farallon Capital Management
Use of proceeds: Develop Freenome's AI/ML multiomics platform, expand commercial and data infrastructure for 2026 test launches, advance multi-cancer detection pipeline
Dec 5, 2025

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024
Revenue0
Selling, general and administrative2.98M658.7K
Operating income-2.98M-494.0K
Depreciation and amortization659
EBITDA-493.3K
Income before tax837.5K1.91M
Net income837.5K1.91M
Earnings per share, basic0.100.23

Balance sheet

LineFY2025FY2024
Cash and equivalents865.0K1.13M
Current assets907.6K1.24M
Total assets92.8M89.9M
Current liabilities2.25M210.8K
Total liabilities5.70M3.66M
Shareholders' equity87.1M86.2M
Shares outstanding8.63M8.35M

Cash flow

LineFY2025FY2024
Cash from operations-864.7K-713.3K
Capital spending00
Free cash flow-864.7K-713.3K
Cash from investing600.0K-86.3M
Cash from financing088.1M
Change in cash-264.7K1.13M

Open Financials

Cap table

Built by 6ix from Perceptive Capital Solutions Corp’s releases · as of Dec 5, 2025

Common shares
8,157,242
Fully diluted
8,157,242

Fully diluted

LineShares
Common shares8,157,242

Share count over time

CountShares
Nov 22, 20268,157,242

Open Cap table

Shareholders

Funds

HolderSharesValueAs of
Fidelity Nasdaq Composite Index Fund8,758US$97,564May 31, 2026

Big stakes

StakeStakeSharesDateFiling
One Fin Capital Management LP9.50%843KMar 31, 2026Schedule 13G
Ra Capital Management, L.P.8.40%750KDec 5, 2025Schedule 13D
Point72 Asset Management, L.P.5.70%465KJul 7, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Deepa Pakianathan
Other companies: Freenome, Inc. (Chief Executive Officer, a stealth Biotech Company · Since at least Nov 5, 2026); Mereo BioPharma Group plc (Non-Executive Director · Since at least Nov 5, 2026)
Chief Executive Officer · Since at least Nov 5, 2026
Aaron Elliott
Other companies: Freenome, Inc. (Chief Executive Officer, Freenome · Since at least Jul 20, 2026)
Chief Executive Officer · Since at least Dec 5, 2025
Douglas VanOort
Other companies: Freenome, Inc. (Director · Since at least Nov 5, 2026)
Director · Since at least Nov 5, 2026
Jimmy Lin
Other companies: Freenome, Inc. (Chief Scientific Officer · Since at least Nov 4, 2026)
Chief Scientific Officer · Since at least Nov 4, 2026
Julie Tran
Other companies: Freenome, Inc. (Chief People Officer · Since at least Nov 5, 2026)
Chief People Officer · Since at least Nov 5, 2026
Linh H. Le
Other companies: Freenome, Inc. (Chief Financial Officer · Since at least Nov 5, 2026)
Chief Financial Officer · Since at least Nov 5, 2026
Riley Ennis
Other companies: Freenome, Inc. (Co-Founder and Chief Product Officer · Since at least Jul 20, 2026)
Co-Founder and Chief Product Officer · Since at least Nov 5, 2026
Robert Guigley
Other companies: Freenome, Inc. (Chief Commercial Officer · Since at least Nov 5, 2026)
Chief Commercial Officer · Since at least Nov 5, 2026
Sally Howard
Other companies: Freenome, Inc. (Senior Vice President, Regulatory and Quality · Since at least Nov 5, 2026)
Senior Vice President, Regulatory and Quality · Since at least Nov 5, 2026
Thomas Fitzpatrick
Other companies: Freenome, Inc. (Chief Legal Officer · Since at least Nov 5, 2026)
Chief Legal Officer · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Perceptive Capital Solutions Corp.